Anfield Capital Management’s Labcorp LH Stock Holding History

Anfield Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$800	Hold	3	–	–	﹤0.01%	646
2025 Q4	$753	Hold	3	–	–	﹤0.01%	517
2025 Q3	$861	Buy	+3	New	+$804	﹤0.01%	525
2023 Q1	–	Sell	-303	Closed	-$61.2K	–	82
2022 Q4	$61.2K	Sell	303 -700	-70%	-$137K	0.03%	73
2022 Q3	$177K	Buy	1,003 +31	+3%	+$6.35K	0.08%	74
2022 Q2	$196K	Buy	972 +212	+28%	+$45.2K	0.09%	75
2022 Q1	$172K	Buy	760 +561	+282%	+$132K	0.06%	78
2021 Q4	$54K	Buy	199 +182	+1,071%	+$45.1K	0.02%	85
2021 Q3	$4K	Buy	+17	New	+$4.28K	﹤0.01%	98

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Anfield Capital Management's LH Position: Q1 2026 in Review

Anfield Capital Management held its Labcorp (LH) position steady in Q1 2026 at 3 shares worth $800. The position accounts for ﹤0.01% of the portfolio, ranked #646.

Anfield Capital Management first reported a position in LH in Q3 2021 and has held it in 9 quarters since. The position peaked at $196K in Q2 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Anfield Capital Management held 3 shares of Labcorp worth $800 as of Q1 2026.
Anfield Capital Management left its Labcorp share count unchanged in Q1 2026.
Labcorp made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #646 holding.
Anfield Capital Management first reported a position in Labcorp in Q3 2021 and has held it in 9 quarters since.
Anfield Capital Management's Labcorp position peaked at $196K in Q2 2022.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.